Present study findings suggests that BOLD-LFOs are implicated early in AD pathophysiology in an APOE4 dependent manner, adding support for the continued study of BOLD-LFOs in the context of cerebrovascular contributions to AD genetic risk. This evidence concerns the gene APOE and Alzheimer disease.